Analyst firms · Morgan Stanley · SDGR

Morgan Stanley SDGR price target and rating history

Schrodinger Inc. (SDGR) · Health Care

Morgan Stanley rates Schrodinger Inc. (SDGR) Equal-Weight with a $28 price target, as of its latest action on Jul 3, 2025. It has published 3 rating actions on SDGR since September 2021, including 1 upgrade and 1 downgrade.

Current rating
Equal-Weight
Price target
$28
Median target, all firms
Too few
Actions on SDGR
3

Morgan Stanley price target on SDGR

$82$55$2820222023202420252026
Morgan Stanley price target on SDGR, each point a stated target, September 2021 to July 2025.

Every Morgan Stanley rating on SDGR

How other firms rate SDGR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSNeutral$19Aug 14, 2026
BofA SecuritiesBuy$24Dec 15, 2025

Questions about Morgan Stanley and SDGR

What is Morgan Stanley's price target for SDGR?
Morgan Stanley's latest stated price target for Schrodinger Inc. (SDGR) is $28, from its action on Jul 3, 2025.
What is Morgan Stanley's rating on SDGR?
Morgan Stanley rates SDGR Equal-Weight, a neutral rating, as of Jul 3, 2025.
When did Morgan Stanley last change its view on SDGR?
On Jul 3, 2025, Morgan Stanley resumes coverage at Equal-Weight, price target $28.

All Morgan Stanley ratingsSDGR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.